Conmed (CNMD) FCF Payout Ratio Growth (5y) (2017 - 2025)
Conmed (CNMD) FCF Payout Ratio Growth (5y) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.66 Bn | 175.36 Bn | 6.27 Bn |
| 2 | Stryker | 128.55 Bn | 125.68 Bn | 3.81 Bn |
| 3 | Medtronic | 108.38 Bn | 99.16 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.11 Bn | 66.66 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.19 Bn | 43.52 Bn | 1.29 Bn |
| 6 | Dexcom | 28.54 Bn | 27.42 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.37 Bn | 26.09 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.90 Bn | 26.33 Bn | - |
| 9 | Koninklijke Philips | 25.53 Bn | 22.40 Bn | 2.07 Bn |
| 10 | Conmed | 1.33 Bn | 1.29 Bn | 183.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -14.90% |
| Sep 30, 2025 | -6.59% |
| Jun 30, 2025 | -39.24% |
| Mar 31, 2025 | -51.88% |
| Dec 31, 2024 | -0.79% |
| Sep 30, 2024 | -6.27% |
| Jun 30, 2024 | -14.54% |
| Mar 31, 2024 | 18.34% |
| Dec 31, 2023 | -15.80% |
| Sep 30, 2023 | 14.90% |
| Jun 30, 2023 | -3.37% |
| Mar 31, 2023 | -37.19% |
| Dec 31, 2022 | -25.29% |
| Sep 30, 2022 | -11.18% |
| Jun 30, 2022 | 1.23% |
| Mar 31, 2022 | -43.07% |
| Dec 31, 2021 | -20.30% |
| Sep 30, 2021 | 7.87% |
| Jun 30, 2021 | -15.18% |
| Mar 31, 2021 | 24.97% |